chrisvoncsefalvay/vaers-outcomes huggingface dataset:
FELT TIRED; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on JUL-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On JUL-2021, the patient experienced felt tired. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from felt tired on JUL-2021. This report was non-serious.
Pt c/o not feeling well and very weak right after receiving injection, and fell less than 3 hours later, would/ could not eat/drink or walk as usual, became confused and bedbound the same day of vaccination and appetite further deteriorated while weakness and confusion increased.
White scaly patches on skin; Broke out in rash all over the body; This spontaneous case was reported by a consumer and describes the occurrence of ECZEMA (White scaly patches on skin) and RASH (Broke out in rash all over the body) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042I20A) for COVID-19 vaccination.     Concomitant products included SEMAGLUTIDE (OZEMPIC) and EMPAGLIFLOZIN (JARDIANCE) for an unknown indication.    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jan-2021, the patient experienced RASH (Broke out in rash all over the body). On 28-Jan-2021, the patient experienced ECZEMA (White scaly patches on skin). On 27-Jan-2021, RASH (Broke out in rash all over the body) had resolved. At the time of the report, ECZEMA (White scaly patches on skin) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment using Antihistamine for rash was reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Severe headache on the first day. The next morning I noticed a rash around the spot of the vaccine approx 1 1/2" in diameter.  Then later that afternoon, I got a scratchy throat, cough, and the rash has spread to the front of my shoulder (near arm pit) and it is very painful.
Within 10 minutes of receiving the vaccine, patient's left area at the site was red and warm to touch, no inflammation, redness then moved to across both shoulder blades and on to the right arm and down halfway.  Benadryl oral tab administered per orders, within 10 min of Benadryl being taken, redness was starting to subside with no further reactions noted. Patient stayed at clinic for another 20 minutes with no further reactions noted.
My left Lymph node under arm was very swollen .  Lymph node took a week for the swelling to start to fade. The second effect was the left side of my face felt like the after effects of large amount of novacaine wearing off.  left side of my face felt numb and a bit stiff . it made me think off bells palsy but my eye lid was not droopy. It took a few days for the feeling in my left side of my face to return to normal  this happened on the first injection . a few weeks later the second injection I was just tired for a few hours later in the day but did not have the same side effect
Parent's state child has been "very sick and vomiting a lot". Shot record faxed to ER tried to call parents & left 3 messages. Didn't get phone call back.
Slight sorness in arm after shot. 7hrs after vax fever of 102 sustained for 12hrs, severe chills, slight headache. The following day 4/10/21 no fever, slight headache,  exhaustion, and loss of appetite. At 48hrs mark mild nausea and mild headache but, feeling much better.
Admitted for physical deconditioning and severe protein calorie malnutrition.  Also tested positive for COVID but remains asymptomatic
ITCHING, FAINT RASH; H/O SHINGLES NOW PT REPORTS THAT SHE HAD AFTER 2ND DOSE
Severe headache, fever, chills, and muscle ache/pain globally. Mild nausea. Taste and smell changes. General weakness. Unable to work. Difficulty moving with being in pain. All symptoms began ~5 hours after vaccine administration, and they continue to persist with very slow improvement greater than 24 hours from onset. Took 500mg acetaminophen about 24 hours after onset of symptoms for worsening fever and headache.
Left Covid Arm.....huge red area on 9th day with first vaccine....never really bothered me except it traveled around the arm
Flu like symptoms; leg ached; Chills; Headache; arm ached; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms), PAIN IN EXTREMITY (leg ached), CHILLS (Chills), HEADACHE (Headache) and MYALGIA (arm ached) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history information was reported.     On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms), PAIN IN EXTREMITY (leg ached), CHILLS (Chills), HEADACHE (Headache) and MYALGIA (arm ached). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. On 08-Apr-2021, INFLUENZA LIKE ILLNESS (Flu like symptoms), PAIN IN EXTREMITY (leg ached), CHILLS (Chills) and HEADACHE (Headache) had resolved. At the time of the report, MYALGIA (arm ached) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications were reported.    This case was linked to MOD-2021-202042 (Patient Link).
This spontaneous report was received from a healthcare worker and refers to a 67 year old male patient. He did not have any pertinent medical history, drug reactions or allergies. On 26-AUG-2015, the patient was vaccinated with PNEUMOVAX 23 injection, 0.5 ml, intramuscularly, lot # I003188, expiration date 06-JUL-2016 for prevention against pneumonia. The patient's concomitant therapies included unspecified cholesterol medication. On 27-AUG-2015 (also reported as "next day after receiving PNEUMOVAX 23"), the patient developed redness, swelling and "hot" at the injection site as well as fluid around the elbow. He sought medical attention and was seen by an unspecified physician on an unspecified date. On an unspecified date, the patient was give prednisolone (manufacturer unknown) as a treatment for the events. On an unspecified date after receiving PNEUMOVAX 23, a complete blood count, comprehensive metabolic panel and lipid panel were carried out (no results were provided). At the time of the report, the patient was recovering from the events. Relatedness between the events and PNEUMOVAX 23 was not reported. This is one of several reports from the same reporter. Additional information has been requested.
I was a patient at a nursing home when I got my vaccine. I was the only resident to get COVID-19. 12 days after my vaccination I woke up congested and with fever. I did take a COVID-19 Home test that was positive. I went to call the nurse hotline and they told me to Isolate for 5 days, later I woke up much sicker. The third time awaking I had temperature of 104. I was very ill, the nurse I called had called 911. I was taken to University Medical Center. I don't remember if they gave me oxygen on the way. I was transported by ambulance. I was tested again and was positive. I don't remember a lot of what happened but my O2 stats were 90 and I was put on oxygen and then during the course my blood pressure top number was 70. Things moved fast after that. I have hypertension and high blood pressure. It tanked in the ER. I was placed on all different IVs of fluids and medicine, I think. At one point I was told to keep my eyes open to show I was conscious. I was in the hospital 5 days. I was taken of oxygen pretty fast; I did have pneumonia but not was affected in my lungs. My blood pressure did start to improve so I was not taken to ICU. I was told to quarantine for 10 days after being discharged. I was taken Levaquin for the pneumonia and made a follow up with my Primary Care Physician. I was very weak and tired for a few weeks it all went away. My follow up visit was fine, my lungs sounded good, the only problem was a few weeks later I started developing blood clots in my left arm. I am now under my PCP seeing him once a month to monitor the blood clots. They are not sure if it's COVID-19 related.
Patient developed pain in left calf, bruising behind knee. Went to ER, ultrasound showed deep vein thrombosis of gastrocnemius veins
Chills (severe shivering), fever (102), nausea, vomiting.  Worst symptoms over in 2-3 hours. Back to normal after 10 hours.
This spontaneous report was received from a healthcare worker refers to an unspecified number of patients of unknown demographics. Patients medical history and concurrent conditions were not reported. From 20-APR-2015 to 29-APR-2015, oral, ROTATEQ (lot # K010224, expiration date: 13-MAY-2016) was improperly exposed to 26F for about 216 hours. On an unknown date in 2015, unspecified number of patients might receive oral, ROATTEQ (dose was unknown) which were improperly stored. Concomitant medications were unspecified by reporter. No known adverse effects reported. The outcome of the events was unknown. This is one of several reports received from the same reporter. Additional information has been requested.
This case was reported by a pharmacist and described an adult subject of unspecified gender who had a decreased response to vaccination with hepatitis B vaccine recombinant Engerix B, for prophylaxis. the pharmacist states that, four nurses, had a decreased response to vaccination with Engerix B, however patient identifiers were not provided. The pharmacist reported that she, believes that the nurses were probably overweight, smokers and of ethnic origin. On an unspecified date before May 13 2005, the subject received a dose of Engerix B (dose number not provided). At an unspecified time after vaccination with Engerix B, on or before May 13 2005, a hepatitis B surface antibody titer was less than 5 mIU/ml.
red, itchy area of little red bumps around 3 inches in size; red bumps around 3 inches in size near injection site; local injection site reaction that is slightly sore; red, itchy red bumps around 3 inches in size at injection site near injection site; Initial information received on 29-Sep-2020 regarding an unsolicited valid non-serious case received from a consumer.  This case involves a 54 years old female patient who experienced red, itchy area of little red bumps around 3 inches in size (pruritus), (rash erythematous), (vaccination site reaction) and local injection site reaction that is slightly sore (vaccination site pain), while she received vaccine INFLUENZA QUADRIVAL A-B MULTIDOSE VACCINE PRESERVED.  Patient once had an Ear infection and treated with an oral steroid. The patient's vaccination(s) included influenza vaccine for prophylactic vaccination. The patient's medical treatment(s) and family history were not provided.  Concomitant medications included DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL N).  On an unknown date, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B MULTIDOSE VACCINE PRESERVED (lot number and expiry date not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed non-serious red, itchy area of little red bumps around 3 inches in size (pruritus), (rash erythematous), (vaccination site reaction) and local injection site reaction that is slightly sore (vaccination site pain) around two hours following the administration of INFLUENZA QUADRIVAL A-B MULTIDOSE VACCINE PRESERVED.  Details of laboratory data were not reported.  Patient used topical steroid.  At the time of reporting, outcome of the events were unknown.  There will be no information available on batch number for this case.
Patient passed out after recieving the vaccine. Nurse states she had a difficult time reviving him. Onsite EMS was called BP 72/51 HR 89, then severed minutes later BP 75/46. Patient went to hospital.
Patient has experienced swelling site of injection.  She has severe dizziness, nausea, low grade fever, body ache.  Her symptoms are vary from day to day, some improvement but occasionally experiences severe dizziness.  She sees doctor for nausea medication, Zofran.  Patient mentions she had Covid 19 infection on December 2020, it lasted 4 months for cough, nausea vomiting, and dizziness.
had a sore arm after getting the vaccine; This spontaneous case was reported by a non-health professional and describes the occurrence of VACCINATION SITE PAIN (had a sore arm after getting the vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (had a sore arm after getting the vaccine). At the time of the report, VACCINATION SITE PAIN (had a sore arm after getting the vaccine) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication and treatment drug were not reported.
administered pentacel to a 7 month old patient of only the liquid dtap/ipv portion and not the acthib component of pentacel with no reported adverse event; DTAP-IPV and ACTHIB components given as 2 separate injections with no reported adverse event.; Initial information received on 14-Mar-2023 regarding an unsolicited valid  non-serious case received from a other health professional.  This case involves a 7 months old female patient to whom administered diphtheria/tetanus/5 hybrid AC pertussis/IPV(VERO)/HIB(PRP/T) vaccine [Pentacel (VERO)] of only the liquid dtap/ipv portion and not the haemophilus type B (HIB) vaccine (HIB (PRP/T) vaccine) [ACT-HIB] component of pentacel with no reported adverse event and dtap-ipv and acthib components given as 2 separate injections with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included pneumococcal vaccine CONJ 13V (CRM197) (Prevnar 13) for Prophylactic vaccination.  On 01-Mar-2023, the patient received a dose 3 at 0.5 mL dose of suspect diphtheria/tetanus/5 hybrid AC pertussis/IPV(VERO)/HIB(PRP/T) vaccine, suspension for injection, (strength and lot number: not reported) (expiry date: 09-Sep-2023) via intramuscular route in right leg and unknown dose of suspect HIB (PRP/T) vaccine , powder and solvent for solution for injection, (lot number: UJ680AA) (strength and expiry date: not reported) via unknown route in unknown administration site for immunization.  On 01-Mar-2023, to the patient administered pentacel to a 7 month old patient of only the liquid dtap/ipv portion and not the acthib component of pentacel with no reported adverse event (single component of a two-component product administered) and dtap-ipv and acthib components given as 2 separate injections with no reported adverse event (wrong technique in product usage process) (latency: same day) following the administration of diphtheria/tetanus/5 hybrid AC pertussis/IPV(VERO)/HIB(PRP/T) vaccine and HIB (PRP/T) vaccine.  No lab data was reported.  Action taken was not applicable.  At time of reporting, the outcome was Unknown for the events.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
sweating; really hot; headache; vomiting; fever; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (sweating), FEELING HOT (really hot), HEADACHE (headache), VOMITING (vomiting) and PYREXIA (fever) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004B21A and 004B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HYPERHIDROSIS (sweating), FEELING HOT (really hot), HEADACHE (headache), VOMITING (vomiting) and PYREXIA (fever). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Adverse event, at an unspecified dose and frequency. At the time of the report, HYPERHIDROSIS (sweating), FEELING HOT (really hot), HEADACHE (headache), VOMITING (vomiting) and PYREXIA (fever) outcome was unknown.            No relevant concomitant medications were provided. No treatment information was provided.
Blood in urine/Didnt put it together until mom also had at same time this week and we were both vaxed on same day; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A female patient received BNT162b2 (BNT162B2), on 30Sep2022 as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunization. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: BLOOD URINE PRESENT (non-serious) with onset Oct2022, outcome "unknown", described as "Blood in urine/Didnt put it together until mom also had at same time this week and we were both vaxed on same day". Additional information: Reporter stated that Blood in urine, had happened anywhere from 1 day to 2 plus weeks after injections. Didn't put it together until mom also had at same time this week and we were both vaxed on same day  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202201246463 Same reporter/vaccine/event, different patient.
Pt brought to ED with nausea, vomiting, diarrhea x past 2 wks; c/o CP and SOB also past 4 days; AMS; was hypotensive with severe respiratory distress; intubated and placed on vasopressors; found to be positive for COVID; given ABX and steroids; CT of abdomen showed enteritis in bowel; worsening renal failure; family transitioned pt to comfort measures; extubated and he passed away in the hospital
Cough; Administered the shot in the upper arm. It was below his shoulder, toward the triceps in the lower deltoid muscle.; This spontaneous case was reported by an other caregiver and describes the occurrence of COUGH (Cough) and INCORRECT ROUTE OF PRODUCT ADMINISTRATION (Administered the shot in the upper arm. It was below his shoulder, toward the triceps in the lower deltoid muscle.) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030A21A and 039K20A) for COVID-19 vaccination.     Concurrent medical conditions included Thyroid disorder.   On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 05-Mar-2021, the patient experienced COUGH (Cough) and INCORRECT ROUTE OF PRODUCT ADMINISTRATION (Administered the shot in the upper arm. It was below his shoulder, toward the triceps in the lower deltoid muscle.). At the time of the report, COUGH (Cough) and INCORRECT ROUTE OF PRODUCT ADMINISTRATION (Administered the shot in the upper arm. It was below his shoulder, toward the triceps in the lower deltoid muscle.) outcome was unknown.            Products known to have been used by the patient, within two weeks prior to the event, included thyroid medication.  Vaccine was administered below patient's shoulder, toward the triceps, in the lower deltoid muscle.  Treatment information was not provided.   This case was linked to MOD-2021-037146 (Patient Link).
Swelling and redness approx 10cm round. Tender to touch. Ice and TYLENOL treatment, (L) anterior thigh.
Got one shot needle broke vaccine came out of syringe. Got poked again vaccine went in.  Waited for 15 min felt fine.  Went to work.  Got home and went to bed.  Woke up At 3am with chills and feeling like having withdrawals  Took some ibuprofen and Tylenol wrapped up with blankets and heating pad.  Woke up drenched in sweat and feeling sore by 6am  Tossed and turned could not go back to sleep Had a small soup for breakfast no appetite  Snaked all day on the couch had flu like symptoms very sore from restless night.  7pm tried to sleep but could not took Benadryl  Slept for 2 hours then woke up from a hot sweat could not return to sleep.  Tossed and turned restless night.  Got out of bed at noon felt sick with heat flashes and sore body.  By Sunday night had a few alcoholic beverages and then felt fine.
At 0843 vaccinator administered first shot in the five shot series of anthrax to PT. At 0843 Pt began to complain of symptoms of feeling lightheaded after vaccinator administered the second vaccine IPOL in the opposite arm. Within several seconds the PT became unresponsive to verbal prompts or painful stimuli and also showed symptoms of Mydriasis, perspiration and paleness. The second vaccinator went to collect the help of two providers and a vital monitoring machine. At 0845 Pt regained a full state of consciousness and was given water to drink while being examined by the providers. At 0847 1st set of vitals was taken and a second and third were taken at 0852 and 0857. At 0858 the providers determined the Pt had made a full recovery and was able to use the restroom upon request.
Child awoke during night with posterior scalp itching severely.  Upon awakening in morning, lower lip was very swollen.  Bilateral forearms with hives, itching, and redness.  No swelling of tongue, throat, etc.  Gave Benadryl 50 mg.  Called child's pediatrician and allergist.
Got dose #1 of Shingrix a couple of months of the Pfizer COVID vaccine.  Decided to delay dose #2 because I didn't want it to interfere with my immune response to the COVID vaccine.  Got Pfizer vaccine on Dec. 28, 2020 (R arm), then dose #2 on Jan 19, 2021(L arm).  Developed L underarm lymphadenopathy a little less than one month after dose #2 of Pfizer vaccine.  On April 22nd, got dose #2 of the Shingrix vaccine on the right arm.  36 hours after second Shingrix vaccine, had fevers and chills.  Thought it was just the vaccine response.  Then 50 hours after vaccine, got severe epigastric pain and continued with fever and chills.  Took ibuprofen.  Then next day around 80 hours after vaccine, developed severe lower abdominal pain and went to the ER.  Diagnosed with acute appendicitis with perforation.
An website editor reported that a consumer of unknown age said that he was vaccinated with Hep B (manufacturer was unknown). No other co-suspects were reported. No concomitant medications were reported. On an unknown date the patient experienced arm was inflamed and itching. No treatment information was reported. The outcome of arm was inflamed and arm is itching was unknown. The relatedness for arm was inflamed and arm was itching was unknown for Hep B. Additional information has been requested.